The pathogenesis of pituitary tumours.
Asa
Sylvia L
SL
Department of Pathology and Laboratory Medicine, University of Toronto, University Health Network and Toronto Medical Laboratories, 610 University Avenue, Toronto, Ontario, Canada M5G 2M5. sylvia.asa@uhn.on.ca
Ezzat
Shereen
S
D000236:Adenoma / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D000818:Animals; D002453:Cell Cycle; D002455:Cell Division; D002999:Clone Cells / Q000473:pathology; D005246:Feedback; D005544:Forecasting; D019204:GTP-Binding Proteins / Q000502:physiology; D006133:Growth Substances / Q000502:physiology; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008822:Mice, Transgenic; D009363:Neoplasm Proteins / Q000502:physiology; D010907:Pituitary Hormones / Q000502:physiology; D010911:Pituitary Neoplasms / Q000453:epidemiology / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D011494:Protein Kinases / Q000502:physiology; D017978:Receptors, Growth Factor / Q000502:physiology; D015398:Signal Transduction
D006133:Growth Substances; D009363:Neoplasm Proteins; D010907:Pituitary Hormones; D017978:Receptors, Growth Factor; D011494:Protein Kinases; D019204:GTP-Binding Proteins